StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research report report published on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Stock Performance Shares of NASDAQ:ABIO opened at $1.75 on Thursday. ARCA biopharma has a 52-week low of $1.74 and a 52-week […]